These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 26881378)

  • 1. Pharmacy Expenditures for Children With Serious Chronic Illness.
    Ruble JH; Brixner DI
    JAMA; 2016 Feb; 315(7):706. PubMed ID: 26881378
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacy Expenditures for Children With Serious Chronic Illness--Reply.
    Chamberlain LJ; Swenson SM; Wise PH
    JAMA; 2016 Feb; 315(7):706-7. PubMed ID: 26881379
    [No Abstract]   [Full Text] [Related]  

  • 3. Outpatient Pharmacy Expenditures for Children With Serious Chronic Illness in California, 2010-2012.
    Swenson SM; Chamberlain LJ; Sanders LM; Sundaram V; Wise PH
    JAMA; 2015 Jul; 314(4):405-7. PubMed ID: 26219060
    [No Abstract]   [Full Text] [Related]  

  • 4. Living arrangements, chronic diseases, and prescription drug expenditures among Korean elderly: vulnerability to potential medication underuse.
    Park EJ; Sohn HS; Lee EK; Kwon JW
    BMC Public Health; 2014 Dec; 14():1284. PubMed ID: 25516064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of a copay increase on pharmaceutical utilization, expenditures, and treatment continuation.
    Motheral BR; Henderson R
    Am J Manag Care; 1999 Nov; 5(11):1383-94. PubMed ID: 10662412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IMS updates HMM's pharmacy indexes.
    Doyle JJ
    Hosp Mater Manage; 1991 Jan; 16(1):19-22. PubMed ID: 10170632
    [No Abstract]   [Full Text] [Related]  

  • 7. Cephalosporin prices rising in wake of Pryor bill.
    Barlow RD
    Hosp Mater Manage; 1991 Jul; 16(7):1, 12-3. PubMed ID: 10112311
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment patterns and costs for anti-TNFα biologic therapy in patients with psoriatic arthritis.
    Palmer JB; Li Y; Herrera V; Liao M; Tran M; Ozturk ZE
    BMC Musculoskelet Disord; 2016 Jun; 17():261. PubMed ID: 27301458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronically ill and prescription charges.
    Bailey RR; Lynn KL; Swainson CP; Frendin TJ; Walker RJ
    N Z Med J; 1985 Feb; 98(773):111. PubMed ID: 3856157
    [No Abstract]   [Full Text] [Related]  

  • 10. Healthcare costs in postmenopausal women with hormone-positive metastatic breast cancer.
    Lage MJ; Borker R; Barber B; Gao S
    J Med Econ; 2010; 13(4):691-7. PubMed ID: 21070099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of a Value-based Formulary on Medication Utilization, Health Services Utilization, and Expenditures.
    Yeung K; Basu A; Hansen RN; Watkins JB; Sullivan SD
    Med Care; 2017 Feb; 55(2):191-198. PubMed ID: 27579915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychotropic medication expenditures for community-dwelling elderly persons.
    Aparasu R; Mort J; Brandt H
    Psychiatr Serv; 2003 May; 54(5):739-42. PubMed ID: 12719508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription medicines: the costs, the benefits, and the promise.
    Ingram RA
    N C Med J; 2003; 64(6):275-7. PubMed ID: 14983615
    [No Abstract]   [Full Text] [Related]  

  • 14. Characteristics of patients receiving pharmaceutical samples and association between sample receipt and out-of-pocket prescription costs.
    Alexander GC; Zhang J; Basu A
    Med Care; 2008 Apr; 46(4):394-402. PubMed ID: 18362819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicaid prescription drug utilization and expenditures following Part D.
    Farley JF; Dusetzina SB
    J Health Care Poor Underserved; 2010 May; 21(2):715-28. PubMed ID: 20453368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost of entry: An analysis of pharmaceutical registration fees in low-, middle-, and high-income countries.
    Morgan SG; Yau B; Lumpkin MM
    PLoS One; 2017; 12(8):e0182742. PubMed ID: 28809931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C drug maker puts profit ahead of patients, US Senate report charges.
    McCarthy M
    BMJ; 2015 Dec; 351():h6573. PubMed ID: 26635239
    [No Abstract]   [Full Text] [Related]  

  • 18. How much do drugs cost your patients?
    Martin S
    CMAJ; 2003 Jun; 168(13):1700. PubMed ID: 12821635
    [No Abstract]   [Full Text] [Related]  

  • 19. Gender differences in drug use and expenditures in a privately insured population of older adults.
    Correa-de-Araujo R; Miller GE; Banthin JS; Trinh Y
    J Womens Health (Larchmt); 2005; 14(1):73-81. PubMed ID: 15692281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective study of direct cost to patients associated with the use of oral oncology medications for the treatment of multiple myeloma.
    Lee C; Grigorian M; Nolan R; Binder G; Rice G
    J Med Econ; 2016; 19(4):397-402. PubMed ID: 26652728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.